Skip to content

Globus Medical

US · GMED #1454 by market cap Listed 1970
66.89 -1.71 -2.49%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 67.28 -1.92%
After-hours 66.89 0.00%
Overnight 68.00 -0.87%
88.3466.8966.892026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on GMED?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bearish
  • Recent price momentum is -20.3% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 7.0% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A
ValuationGrowthProfitMomentumHealthAnalyst
Valuation B+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 16.5x Better than 54%
Forward P/E 16.0x Better than 52%
Price / Sales 3.0x Better than 41%
P/E vs own 5-yr range 1st pctl Better than 99%
Growth A+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 42.2% Better than 94%
Net income CAGR (3Y) 41.4% Better than 86%
Free cash flow CAGR (3Y) 77.0% Better than 90%
Profitability A-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 67.4% Better than 81%
Operating margin 18.3% Better than 73%
Net margin 18.3% Better than 77%
Return on equity 12.3% Better than 60%
Return on invested capital 11.4% Better than 73%
Momentum C-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -23.0% Better than 26%
6-month return -21.1% Better than 26%
12-month return (ex latest month) -5.4% Better than 27%
Distance below 52-week high 34.0% Better than 36%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 4.3x Better than 82%
Debt to assets 2.2% Better than 87%
Interest coverage -9.9x Better than 13%
Free cash flow / net income 107.7% Better than 44%
Analyst View B

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 70.0% Better than 48%
Upside to average target 39.4% Better than 59%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -7.28%
1M -15.29%
3M -21.92%
6M -20.40%
YTD -23.39%
1Y -18.70%
3Y +47.40%
5Y -1.09%

Key statistics

Price & volume

Prev close
68.60
Open
68.44
Day range
66.63 - 69.54
Avg price
67.50
Volume
1.51M
Turnover
102.09M
Amplitude
4.24%
52-week range
66.63 - 101.40

Valuation

P/E
17.06
P/E (TTM)
16.48
P/B
1.85
EPS
3.92
Net profit
519.29M
Net assets
4.80B

Share structure

Market cap
8.86B
Float cap
7.30B
Shares out
132.47M
Float shares
109.14M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 1% of range
66.63 101.40

34.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-91.70M net over the window

Short interest

Shares short
9.46M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Globus Medical (GMED)?

Globus Medical last traded at 66.89. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Globus Medical's market cap?

About 8.86B.

What is the P/E ratio of Globus Medical?

The trailing twelve-month P/E is 16.48, below its own 5-year average of 63.63 — toward the bottom of its historical range (0.72% percentile). See the Valuation tab for the full history.

Does Globus Medical pay a dividend?

Globus Medical does not currently pay a regular dividend.

Is Globus Medical a buy according to analysts?

The consensus of 10 analysts is a Buy rating, with an average 12-month price target of 93.25, which implies 39.4% upside from the current price. This is not investment advice.

What is Globus Medical's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Globus Medical a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Globus Medical discussion 0 comments

Add a comment